Selected article for: "common pathway and wide range"

Author: Del Prete, Anna; Scalera, Antonella; Iadevaia, Maddalena Diana; Miranda, Agnese; Zulli, Claudio; Gaeta, Laura; Tuccillo, Concetta; Federico, Alessandro; Loguercio, Carmelina
Title: Herbal Products: Benefits, Limits, and Applications in Chronic Liver Disease
  • Cord-id: gbyqrxg2
  • Document date: 2012_9_6
  • ID: gbyqrxg2
    Snippet: Complementary and alternative medicine soughts and encompasses a wide range of approaches; its use begun in ancient China at the time of Xia dynasty and in India during the Vedic period, but thanks to its long-lasting curative effect, easy availability, natural way of healing, and poor side-effects it is gaining importance throughout the world in clinical practice. We conducted a review describing the effects and the limits of using herbal products in chronic liver disease, focusing our attentio
    Document: Complementary and alternative medicine soughts and encompasses a wide range of approaches; its use begun in ancient China at the time of Xia dynasty and in India during the Vedic period, but thanks to its long-lasting curative effect, easy availability, natural way of healing, and poor side-effects it is gaining importance throughout the world in clinical practice. We conducted a review describing the effects and the limits of using herbal products in chronic liver disease, focusing our attention on those most known, such as quercetin or curcumin. We tried to describe their pharmacokinetics, biological properties, and their beneficial effects (as antioxidant role) in metabolic, alcoholic, and viral hepatitis (considering that oxidative stress is the common pathway of chronic liver diseases of different etiology). The main limit of applicability of CAM comes from the lacking of randomized, placebo-controlled clinical trials giving a real proof of efficacy of those products, so that anecdotal success and personal experience are frequently the driving force for acceptance of CAM in the population.

    Search related documents:
    Co phrase search for related documents
    • adipose tissue and adjuvant therapy: 1, 2
    • adipose tissue and liver cell: 1
    • adipose tissue and liver damage: 1, 2, 3, 4, 5
    • adipose tissue and liver direct effect: 1
    • adipose tissue and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • adipose tissue and liver enzyme: 1, 2
    • adipose tissue and liver fat accumulation: 1, 2
    • adipose tissue and liver fibrosis: 1, 2, 3, 4
    • adipose tissue and liver function: 1, 2, 3
    • adipose tissue and liver gene expression: 1, 2, 3
    • adipose tissue and liver histopathology: 1
    • adipose tissue and liver inflammation: 1, 2, 3, 4
    • adipose tissue and liver injury: 1, 2, 3, 4, 5
    • adipose tissue and liver small intestine: 1, 2
    • adipose tissue and liver steatosis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • adipose tissue and liver tissue: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42
    • adipose tissue and liver tissue inflammation hepatic steatosis: 1
    • adipose tissue and long term administration: 1
    • liver disease and long term administration: 1